State Street’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $102K | Buy |
|
|||||
|
2025
Q1 | $83K | Buy |
|
|||||
|
2024
Q4 | $216K | Buy |
|
|||||
|
2024
Q3 | $377K | Buy |
|
|||||
|
2024
Q2 | $381K | Buy |
|
|||||
|
2024
Q1 | $494K | Buy |
|
|||||
|
2023
Q4 | $242K | Buy |
|
|||||
|
2023
Q3 | $233K | Buy |
|
|||||
|
2023
Q2 | $269K | Buy |
|
|||||
|
2023
Q1 | $310K | Buy |
|
|||||
|
2022
Q4 | $392K | Sell |
|
|||||
|
2022
Q3 | $332K | Sell |
|
|||||
|
2022
Q2 | $623K | Sell |
|
|||||
|
2022
Q1 | $1.32M | Buy |
|
|||||
|
2021
Q4 | $2.31M | Buy |
|
|||||
|
2021
Q3 | $2.94M | Buy |
|
|||||
|
2021
Q2 | $1.11M | Sell |
|
|||||
|
2021
Q1 | $2.16M | Buy |
|
|||||
|
2020
Q4 | $1.94M | Buy |
|
|||||
|
2020
Q3 | $1.64M | Buy |
|
|||||
|
2020
Q2 | $1.72M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $155K | Sell |
|
|||||
|
2019
Q1 | $170K | Sell |
|
|||||
|
2018
Q4 | $234K | Buy |
|
|||||
|
2018
Q3 | $492K | Hold |
|
|||||
|
2018
Q2 | $431K | Sell |
|
|||||
|
2018
Q1 | $424K | Sell |
|
|||||
|
2017
Q4 | $678K | Sell |
|
|||||
|
2017
Q3 | $837K | Buy |
|
|||||
|
2017
Q2 | $295K | Hold |
|
|||||
|
2017
Q1 | $363K | Hold |
|
|||||
|
2016
Q4 | $266K | Hold |
|
|||||
|
2016
Q3 | $464K | Hold |
|
|||||
|
2016
Q2 | $536K | Hold |
|
|||||
|
2016
Q1 | $535K | Hold |
|
|||||
|
2015
Q4 | $794K | Buy |
|